LISINOPRIL-FORMULIERUNGEN

Patent europeic · EP3368012 · Stritgà

Inscripziun en il register

Numer da publicaziun: EP3368012
Numer da la dumonda: EP16860888
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: Stritgà
Scrittira da patent: Concedì
Annunzià: 28-10-2016
Publitgà: 05-09-2018
Concedì: 11-08-2021
Stritgà: 01-06-2022
Motiv: Taxa annuala betg pajada
Classas IPC: A61K 9/00 (2006.01)
A61K 31/401 (2006.01)
A61K 38/55 (2006.01)
A61K 38/05 (2006.01)
A61K 47/02 (2006.01)
A61K 47/12 (2006.01)
A61K 47/26 (2006.01)
A61P 9/04 (2006.01)
A61P 9/12 (2006.01)
A61P 43/00 (2006.01)
Prioritad: US 201562249011 P 30.10.2015
US 201514934752 06.11.2015
Dumonda PCT: PCT/US2016/059348 28.10.2016
Publicaziun PCT: WO2017/075368 04.05.2017
Lingua da l’annunzia: englais
Funtauna: Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

22-06-2022
Midada
Published in Swissreg on 22.06.2022
01-06-2022
Stritgà, taxa betg pajada
Published in Swissreg on 01.06.2022
11-08-2021
Concedì
Published in Swissreg on 11.08.2021

Partidas

Possessur

Silvergate Pharmaceuticals, Inc.

6251 Greenwood Plaza Blvd. Suite 101, Greenwood Village, CO 80111, US

Inventur

MOSHER, Gerold L.

Kansas City, MS 64145, US

MILES, David W.

Kansas City, MS 64145, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.